About LUNAI BIOWORKS, INC.
Lunai Bioworks is a phenomics-driven drug discovery company that integrates AI, phenomics, and living biological systems to decode disease biology and develop precise, clinically relevant therapies. The company focuses on oncology, neurology, and biosecurity.
Integrates genomic, proteomic, and phenotypic data into one view of diseaseIdentifies hidden signatures that conventional methods miss, uncovering therapeutic targets and biomarkersTransforms raw insights into therapeutic strategies with prioritization by druggability, patient stratification, and clinical feasibilityUses living zebrafish models with AI analysis to uncover mechanisms and treatment effectsProvides predictive biomarkers for patient stratification in oncologyIntegrates behavioral, electrical, and physiological signals for neurology disorders like epilepsyOffers real-time neurotoxicity assessment for biosecurity applications
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LUNAI BIOWORKS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.